Skip to main content
Equibles

BARCLAYS PLC

Position in DSGN — Design Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$169,400
-$424,205 QoQ
Shares Held
11,707
-79.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 136 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. DSGN ranks #223 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in DSGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $169,400 11,707
2026-03-31 $593,605 55,790
2025-12-31 $816,622 87,060
2025-09-30 $663,964 88,176
2025-06-30 $369,136 109,536
2025-03-31 $324,263 84,006
2024-12-31 $639,033 103,571
2024-09-30 $519,896 96,635
2024-06-30 $241,310 72,033
2024-03-31 $358,299 88,908
2023-12-31 $294,028 110,954
2023-09-30 $169,160 71,678
2023-06-30 $99,665 15,820
2023-03-31 $99,342 17,217
2022-12-31 $1,344,048 130,999
2022-09-30 $361,118 21,598
2022-06-30 $2,877,910 205,565
2022-03-31 $3,658,152 226,511